360
Participants
Start Date
March 16, 2018
Primary Completion Date
September 13, 2019
Study Completion Date
October 26, 2019
L-arginine 1.4% 500 ml
Infusion of L-arginine 1.4% solution by 500 ml (2 vials 250 ml each) IV daily for 10 days
L-arginine 1.4% 250 ml + placebo 250 ml
Infusion of L-arginine 1.4% solution 250 ml IV daily for 10 days and placebo infusion by 250 ml IV daily for 10 days.
Placebo solution
Infusion of Ringer's solution by 500 ml (2 vials 250 ml each) IV daily for 10 days
Regional Clinical Hospital, Barnaul
Kursk City Clinical Emergency Hospital, Kursk
City Clinical Hospital № 15 named O.M. Filatov, Moscow
Medical and sanitary Department of the Ministry of Internal Affairs of the Russian Federation in Moscow, Moscow
City Clinical Hospital №2 of the Novosibirsk Region, Novosibirsk
National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk
State Novosibirsk Regional Clinical Hospital, Novosibirsk
"Multidisciplinary center of modern medicine Euromed", Omsk
Orenburg Regional Clinical Hospital, Orenburg
Rostov State Medical University, Rostov-on-Don
Ryazan Regional Clinical Cardiological dispensary, Ryazan
City General Hospital №2, Saint Petersburg
City Hospital №38 named after N.A. Semashko, Saint Petersburg
Consultative and diagnostic center No. 85, Saint Petersburg
Road Clinical Hospital of the Russian Railways Open Joint-Stock Company, Saint Petersburg
St. Petersburg State Medical University n.a. I.P.Pavlov, Saint Petersburg
Regional Clinical Cardiology Dispensary, Saratov
Clinical hospital №10 of the Yaroslavl region, Yaroslavl
Regional Clinical Hospital of the Yaroslavl region, Yaroslavl
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY